DHR - Kewajiban jangka dawa perusahaan Danaher Corporation

Danaher Corp. develops advanced biopharmaceutical technologies and laboratory diagnostics through large-scale R&D investments. The company's long-term debt metric clearly demonstrates the dynamics of its liabilities, where the parameter value equals 22.78. Stability is ensured by a business model based on the sale of consumables for high-cost equipment and a flawlessly optimized global supply chain that minimizes any logistical delays.

The scalability of the Danaher Corp. (DHR) business system requires significant investment, which is reflected in the trend of the issuer's long-term liabilities. This indicator captures the total volume of borrowed capital with a maturity of over one year to assess long-term solvency. The calculation is based on daily monitoring of debt liabilities, allowing for the tracking of risks associated with rising loan servicing costs amid increasing interest rates. A stable revenue stream from consumables offsets the pressure of the debt load.